NEWS

At We Work For Health (WWFH), our commitment to fostering health equity across the nation goes beyond advocacy—it extends to tangible,...

The biopharmaceutical industry is the backbone of America's innovative economy, supporting more than 4.9 million jobs across the United...

As Congress returned to Washington, the Senate Judiciary Committee held a full committee hearing  to consider a number of critical bills...

New research from the IQVIA Institute for Human Data Science further confirms what We Work For Health (WWFH) and others have warned...

The Drug Price Competition and Patent Term Restoration Act, more commonly known as the Hatch-Waxman Act, profoundly changed the...

As healthcare access and costs continue to dominate political conversations, the flaws in the Inflation Reduction Act are becoming...

In 1984, the Hatch-Waxman Act – formally known as the bipartisan Drug Price Competition and Patent Term Restoration Act  – established a...

During a recent We Work For Health roundtable with California Rep. Scott Peters, leaders across patient advocacy, biopharma, labor,...

American innovation depends on a strong, robust intellectual property system that allows health care advances to save and enhance lives....

We Work For Health recently unveiled a new set of one-page resources designed to highlight the significant impact of the...

A version of this blog originally published as an op-ed in The Center Square in Arizona. We're sharing it here with additional updates...

The Biden administration this week is expected to claim victory on its stated goal of lowering drug prices for seniors. While the...

By Dan Leonard, WWFH Executive Director Intellectual property (IP) plays a crucial role in the success of the pharmaceutical and biotech...

On Monday, the Centers for Medicare and Medicaid Services (CMS) announced 2025 premiums for Medicare Part D plans will increase again....

During an event on Capitol Hill this week, California Rep. Scott Peters highlighted a graphic that clearly illustrates the distorted...

Despite the significant demand for effective non-opioid medications for the treatment of pain, a recent report from the Pioneer Institute...

SAN DIEGO – At a We Work For Health roundtable on June 20, the organization and its partners honored Rep. Scott Peters (CA-50) with the...

The National Institute of Standards and Technology (NIST) may soon finalize its controversial proposal to expand the scope of the...

This week, the largest not-for-profit health insurance provider in Missouri, Blue KC, announced it will leave the Medicare Advantage...

The Centers for Medicare & Medicaid Services (CMS) recently released a final rule allowing Medicare Advantage and Part D health plans to...